Skip to content
WeighLab
Menu
Ranked #438 · Grade C

T2D.com review

T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.

Visit T2D.com Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$999/mo (starting dose, compounded)
Tirzepatide
$999/mo (starting dose, compounded)
Coverage
1 states
Brand-name
Compounded only

Semaglutide · modeled / year

$11,988

Tirzepatide · modeled / year

$11,988

The Index scorecard

T2D.com scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month27/100
Price Transparency30/100
Nationwide Access42/100
Formulation Options66/100
Clinical Oversight69/100
Contract Flexibility55/100

Where the value is

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

The tradeoffs

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

The bottom line

Best for: Cost-first shoppers who want diabetic GLP-1 access. T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.

Ranked #438 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to T2D.com.

The 18 programs nearest this one

Pricing, states and verification reflect T2D.com's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on T2D.com's site. Not medical advice; see our disclosure.

← Back to the value leaderboard